Cadrenal Therapeutics Inc Share Price (NASDAQ: CVKD)

Cadrenal Therapeutics Inc Stock Performance

as on October 16, 2025 at 8:34 pm IST

Day's Low
$13.81
Day's Price Range
$14.06
$14.06
1.78%
Downside
52 Week's Low
52 Week's High
$8.74
52-Week Price Range
$22.9
$14.06
37.84%
Downside
62.88%
Upside

Cadrenal Therapeutics Inc share price movements today

Previous Close: $14.06
Open: $13.98
Volume: 17.7K
Day's Low - High: $13.81 - $14.06
52 Week Low - High: $8.74 - $22.9

Cadrenal Therapeutics Inc Historical Returns

1 Month Return: + 5.36 %
3 Month Return: + 25.92 %
1 Year Return: -8.37 %
3 Year Return: 0 %
5 Year Return: 0 %

Cadrenal Therapeutics Inc Stock Fundamentals & Key Indicators

Check Cadrenal Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$28.9M

EPS (TTM)

-7.19

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-14.4M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

1177300.00%

Cadrenal Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cadrenal Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cadrenal Therapeutics Inc	BUY	$28.9M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.5B	223.43%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.1B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$105.7B	87.04%	28.99	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	-3.89%	14.07	31.37%

Stock Returns calculator for Cadrenal Therapeutics Inc Stock including INR - Dollar returns

The Cadrenal Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Cadrenal Therapeutics Inc investment value today

Current value as on today

₹96,243

Returns

₹3,757

(-3.76%)

Returns from Cadrenal Therapeutics Inc Stock

₹8,404 (-8.4%)

Dollar Returns*

₹4,647 (+4.65%)

Analyst Recommendation on Cadrenal Therapeutics Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Cadrenal Therapeutics Inc. Average target price of $35.67

Cadrenal Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Cadrenal Therapeutics Inc.

What analysts predicted

60.58%UPSIDE

Target Price

$35.67

Current Price

$14.06

Analyzed by

8 Analysts

Target

$35.67

Cadrenal Therapeutics Inc target price $35.67, a slight upside of 60.58% compared to current price of $14.06. According to 8 analysts rating.

Cadrenal Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Cadrenal Therapeutics Inc Stock has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 16, 2025 to October 16, 2025

Change:100% versus previous 30 day period

Cadrenal Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	0	-	-	-	0	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-4	-1	-1	-1	-1	-2	-2	-4	-3	-3
EBITDA	-5	-1	-1	-1	-1	-2	-2	-4	-3	-3
Interest Expense	0	-	-	0	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-5	-1	-1	-1	-1	-2	-2	-4	-3	-3
Income Tax Expense	0	0	0	0	0	-	-	-	-	-
Net Income	-5	-1	-1	-1	-1	-2	-2	-4	-3	-3
Net Profit Margin	0.00%	0.00%	0.00%	-41331.65%	0.00%	0.00%	0.00%	-196216.87%	0.00%	0.00%

Cadrenal Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2023	Dec 2024
Total Revenue	-	-
Gross Profit	0	0
Operating Income	-7	-10
EBITDA	-8	-10
Interest Expense	0	-
Depreciation	0	0
Income Before Tax	-8	-10
Income Tax Expense	0	-
Net Income	-8	-10
Net Profit Margin	0.00%	0.00%

Cadrenal Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-1	-1	-1	-1	-2	-2	-4	-3	-3
Operating Cash Flow	0	0	0	-1	-1	-2	-1	-4	-3
Investing Cash Flow	0	-	-	-	-	-	0	0	0
Financing Cash Flow	0	6	0	0	-	1	7	1	1
Change in Cash	0	5	0	-1	-1	0	5	-2	-1

Cadrenal Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2023	Dec 2024
Net Income	-8	-10
Operating Cash Flow	-3	-7
Investing Cash Flow	0	0
Financing Cash Flow	11	8
Change in Cash	8	1

Insights on Cadrenal Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, CVKD stock has moved up by 25.9%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 56.5% return, outperforming this stock by 64.9%

About Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc. is a biopharmaceutical company focused on developing transformative therapeutics to overcome the gaps in anticoagulation therapy. The Company’s lead investigational product is tecarfarin, a novel oral vitamin K antagonist anticoagulant that is designed to address unmet needs in anticoagulation therapy. Tecarfarin is a reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients requiring chronic anticoagulation. Tecarfarin has orphan drug designation (ODD) for advanced heart failure patients with implanted mechanical circulatory support devices, including left ventricular assisted devices (LVADs). The Company also has ODD and fast-track status for tecarfarin in end-stage kidney disease and atrial fibrillation (ESKD+AFib). It also includes Frunexian, a Phase 2-ready IV Factor XIa agent for acute anticoagulation and EP-7327 is a ready oral small molecule candidate for chronic indications.

Organisation	Cadrenal Therapeutics Inc
Headquarters	822 A1A North, Ponte Vedra, FL, United States, 32082
CEO	Mr. Quang X. Pham
E-voting on shares	Click here to vote

Key Management of Cadrenal Therapeutics Inc

Name	Title
Mr. Quang X. Pham	Chairman & CEO
Mr. Matthew K. Szot CPA, CPA	Co-Founder & CFO
Mr. Jeffrey Cole	Chief Operating Officer
Dr. James J. Ferguson FACC, M.D.	Chief Medical Officer

FAQs

What is Cadrenal Therapeutics Inc share price today?

Cadrenal Therapeutics Inc share price today is $14.06 as on October 16, 2025 at 8:34 pm IST. Cadrenal Therapeutics Inc share today touched a day high of $14.06 and a low of $13.81.

What is the 52 week high and 52 week low for Cadrenal Therapeutics Inc share?

Cadrenal Therapeutics Inc share touched a 52 week high of $22.9 on February 26, 2025 and a 52 week low of $8.74 on August 4, 2025. Cadrenal Therapeutics Inc stock price today i.e. October 16, 2025 at 8:34 pm IST is trending at $14.06,which is 38.61% down from its 52 week high and 60.87% up from its 52 week low.

What is Cadrenal Therapeutics Inc's market capitalisation today?

Cadrenal Therapeutics Inc market capitalisation is $0.00T as on October 16, 2025 at 8:34 pm IST.

How to invest in Cadrenal Therapeutics Inc Stock (CVKD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cadrenal Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cadrenal Therapeutics Inc Shares that will get you 0.1067 shares as per Cadrenal Therapeutics Inc share price of $14.06 per share as on October 16, 2025 at 8:34 pm IST.

What is the minimum amount required to buy Cadrenal Therapeutics Inc Stock (CVKD) from India?

Indian investors can start investing in Cadrenal Therapeutics Inc (CVKD) shares with as little as ₹87.83 or $1 (as of October 16, 2025 at 8:37 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.30 in Cadrenal Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on October 16, 2025 at 8:37 pm IST). Based on Cadrenal Therapeutics Inc share’s latest price of $14.06 as on October 16, 2025 at 8:34 pm IST, you will get 0.7112 shares of Cadrenal Therapeutics Inc. Learn more about fractional shares .